BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23980640)

  • 1. Five-year oncological outcomes of endoscopic extraperitoneal radical prostatectomy (EERPE) for prostate cancer: results from a medium-volume UK centre.
    McNeill SA; Good DW; Stewart GD; Stolzenburg JU
    BJU Int; 2014 Mar; 113(3):449-57. PubMed ID: 23980640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic extraperitoneal radical prostatectomy after previous transurethral resection of prostate: oncologic and functional outcomes of 100 cases.
    Do M; Haefner T; Liatsikos E; Kallidonis P; Hicks J; Dietel A; Horn LC; Rabenalt R; Stolzenburg JU
    Urology; 2010 Jun; 75(6):1348-52. PubMed ID: 19914701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experience.
    Busch J; Stephan C; Herold A; Erber B; Kempkensteffen C; Hinz S; Lein M; Weikert S; Miller K; Magheli A
    BJU Int; 2012 Dec; 110(11 Pt C):E985-90. PubMed ID: 22672442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic extraperitoneal radical prostatectomy (EERPE): a new approach for treatment of localized prostate cancer.
    Srinualnad S; Nualyong C; Udompunturak S; Kongsuwan W
    J Med Assoc Thai; 2006 Oct; 89(10):1601-8. PubMed ID: 17128833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term oncological outcomes after laparoscopic radical prostatectomy.
    Hruza M; Bermejo JL; Flinspach B; Schulze M; Teber D; Rumpelt HJ; Rassweiler JJ
    BJU Int; 2013 Feb; 111(2):271-80. PubMed ID: 22757970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching from Endoscopic Extraperitoneal Radical Prostatectomy to Robot-Assisted Laparoscopic Prostatectomy: Comparing Outcomes and Complications.
    Wagenhoffer R; Gruner M; Schymik J; Schachtner L; Neagoe L; Berg C; Schlichter A; Manseck A
    Urol Int; 2015; 95(4):380-5. PubMed ID: 25833339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncological outcomes after robot-assisted radical prostatectomy: long-term follow-up in 4803 patients.
    Sukumar S; Rogers CG; Trinh QD; Sammon J; Sood A; Stricker H; Peabody JO; Menon M; Diaz-Insua M
    BJU Int; 2014 Dec; 114(6):824-31. PubMed ID: 24053586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer.
    Ritch CR; You C; May AT; Herrell SD; Clark PE; Penson DF; Chang SS; Cookson MS; Smith JA; Barocas DA
    Urology; 2014 Jun; 83(6):1309-15. PubMed ID: 24746665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcome after extraperitoneal laparoscopic radical prostatectomy: midterm follow-up of 1115 procedures.
    Paul A; Ploussard G; Nicolaiew N; Xylinas E; Gillion N; de la Taille A; Vordos D; Hoznek A; Yiou R; Abbou CC; Salomon L
    Eur Urol; 2010 Feb; 57(2):267-72. PubMed ID: 19775807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
    Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
    J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy.
    Shikanov S; Marchetti P; Desai V; Razmaria A; Antic T; Al-Ahmadie H; Zagaja G; Eggener S; Brendler C; Shalhav A
    BJU Int; 2013 Apr; 111(4):559-63. PubMed ID: 22759270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic extraperitoneal radical prostatectomy: oncological and functional results after 700 procedures.
    Stolzenburg JU; Rabenalt R; DO M; Ho K; Dorschner W; Waldkirch E; Jonas U; Schütz A; Horn L; Truss MC
    J Urol; 2005 Oct; 174(4 Pt 1):1271-5; discussion 1275. PubMed ID: 16145391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive surgical margins after minimally invasive radical prostatectomy in patients with pT2 and pT3a disease could be considered pathological upstaging.
    Ouzzane A; Rozet F; Salas RS; Galiano M; Barret E; Prapotnich D; Cathelineau X
    BJU Int; 2014 Apr; 113(4):586-91. PubMed ID: 23889763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive surgical margins and biochemical recurrence following minimally-invasive radical prostatectomy - An analysis of outcomes from a UK tertiary referral centre.
    Sachdeva A; Veeratterapillay R; Voysey A; Kelly K; Johnson MI; Aning J; Soomro NA
    BMC Urol; 2017 Oct; 17(1):91. PubMed ID: 28969608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience.
    Xylinas E; Drouin SJ; Comperat E; Vaessen C; Renard-Penna R; Misrai V; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Roupret M
    BJU Int; 2009 May; 103(9):1173-8; discussion 1178. PubMed ID: 19040530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.
    Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG
    BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for biochemical recurrence following radical perineal prostatectomy in a large contemporary series: a detailed assessment of margin extent and location.
    Sammon JD; Trinh QD; Sukumar S; Ravi P; Friedman A; Sun M; Schmitges J; Jeldres C; Jeong W; Mander N; Peabody JO; Karakiewicz PI; Harris M
    Urol Oncol; 2013 Nov; 31(8):1470-6. PubMed ID: 22534086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of margin status at 37 months after robot assisted radical prostatectomy.
    Warner JN; Nunez RN; Mmeje CO; Colby TV; Ferrigni RG; Humphreys MR; Andrews PE; Castle EP
    Can J Urol; 2011 Dec; 18(6):6043-9. PubMed ID: 22166333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.